{"id":"ag2304r","safety":{"commonSideEffects":[]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"Limited public information is available regarding the specific molecular mechanism of AG2304R. As a phase 3 candidate from Ahn-Gook Pharmaceuticals, it has progressed through early clinical development, but detailed mechanistic data has not been widely disclosed in accessible pharmaceutical databases or literature.","oneSentence":"AG2304R is an investigational therapeutic in phase 3 development by Ahn-Gook Pharmaceuticals with an undisclosed mechanism of action.","_ai_confidence":"low"},"_scrapedAt":"2026-03-28T00:44:19.988Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[]},"trialDetails":[{"nctId":"NCT06717360","phase":"PHASE3","title":"A Phase 3 Clinical Trial to Evaluate the Efficacy and Safety of AG2304T and AG2304R","status":"NOT_YET_RECRUITING","sponsor":"Ahn-Gook Pharmaceuticals Co.,Ltd","startDate":"2025-06","conditions":"Hypercholesterolemia","enrollment":140}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":0,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"phase_3","status":"active","brandName":"AG2304R","genericName":"AG2304R","companyName":"Ahn-Gook Pharmaceuticals Co.,Ltd","companyId":"ahn-gook-pharmaceuticals-co-ltd","modality":"Small molecule","firstApprovalDate":"","aiSummary":"","enrichmentLevel":3,"visitCount":1,"trialStats":{"total":0,"withResults":0},"verificationStatus":"partial","dataCompleteness":{"mechanism":true,"indications":false,"safety":false,"trials":true,"score":2}}